Cannabinoids and drugs
Analysis of new classes of recreational drugs in sewage: Synthetic cannabinoids and amphetamine-like substances
... synthetic cannabinoids by sewage analysis is therefore challenging since these compounds are often sold in mixtures, and it is possible that the level of one particular biomarker may never be sufficiently high to ...
25
Chromatographic analysis and survey studies to evaluate the emerging drugs of synthetic cannabinoids in Scotland and Saudi Arabia
... synthetic cannabinoids (SCs) has increased at an unprecedented pace around the world ...these drugs seem to display more toxicity than THC due to their increased potency and uncontrolled dose that might ...
270
Today's Designer Drugs - Synthetic Cannabinoids ("K2"/ "Spice") and Synthetic Stimulants ("Bath Salts")
... – Current comprehensive panels also include 3 rd generation compounds – e.g. UR-144, XLR-11, MAM-2201, AKB-48, PB-22 (depending on lab) • As the metabolites cannot be detected by routine immunoassay screening techniques ...
42
Emerging drugs of abuse: current perspectives on synthetic cannabinoids
... psychoactive drugs that have appeared over the last decade are typically dominated by cathinones and synthetic cannabinoids ...ational drugs because they mimic the euphoria effect of cannabis while ...
17
Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach
... ABSTRACT Cannabinoids have shown diverse and critical effects on the body systems, which alter the physiological ...Synthetic cannabinoids are comparatively innovative misuse drugs with respect to ...
24
Cannabinoids and zebrafish
... After 5 decades of research, a lot is known about the chemistry and pharmacology of ∆ 9 -THC. Surely, ∆ 9 -THC has been approved by FDA and is being marketed to the pharmacies of U.S.A and Canada. But still the poor ...
179
Cannabinoids in Parkinson’s disease
... The first study consists of an open-label pilot study performed on six patients with the diagnosis of PD and psychosis (Zuardi et al., 2009). Due to the antipsychotic and neuroprotective effects of CBD, the researchers ...
49
The use of cannabinoids in Parkinson’s disease
... critical. Cannabinoids (CBs), which include ∆9-tetrahydrocannabinol, canna- bidiol and ∆9-tetrahydrocannabivarin, target the en- docannabinoid (ECB) system, which is highly involved in dopaminergic ...CB ...
16
Synthetic cannabinoids: The Australian experience
... It was not until early 2011, however, following the growing media interest in the product ‘Kronic’, that Australian authorities began to focus their attention on this rapidly emerging class of drugs. It is ...
10
Cannabinoids : from pot to lab
... synthetic cannabinoids Despite the fact that since ancient times the medicinal properties of cannabis and its use in numerous ailments have been widely documented, it wasn’t included as such in the American and ...
10
Pyrolytic Fate of Synthetic Cannabinoids
... traditional drugs of abuse that are smoked or the relatively new synthetic ...synthetic cannabinoids, but there has yet to be peer-reviewed reports seeking to understand what caused these health ...
215
Towards the use of cannabinoids as antitumour agents
... Combinational therapies The use of combinational anticancer therapies has several theoretical advan- tages over single-agent-based strategies, as they allow the simultaneous targeting of tumour growth, progression and ...
9
Synthetic Cannabinoids: Law vs. Science
... 2 What is a synthetic drug? A synthetic drug, also known by the term designer drug, is a psychoactive substance that has been created due to research and experimentation with previously existing substances. They are ...
26
Synthetic Cannabinoids and Cathinones: Prevalence and Markets
... designer drugs has attracted much attention. Synthetic cannabinoids and cathinones are the two main classes of these ...potent drugs of abuse, and several cases of severe toxicity and deaths are ...
20
Cannabinoids in the management of difficult to treat pain
... Overall, Sativex appears to pose less risk of dependency than smoked cannabis based on its slower onset, lower dos- age utilized in therapy, almost total absence of intoxication in regular usage, and minimal withdrawal ...
16
Systematic review of systematic reviews for medical cannabinoids
... Prescribing cannabinoids clearly has a number of ...medical cannabinoids for inappropri- ate reasons like legalizing or attaining insurance cov- erage for their recreational ...medical cannabinoids ...
17
Tissue Engineering of Cartilage; Can Cannabinoids Help?
... of cannabinoids in enhancing MSC-based tissue-engineered cartilage regeneration ...cannabinoid-based drugs in tissue- engineered applications aimed at reducing cartilage degradation and facilitating ...
16
C annabis and its component cannabinoids (particularly
... p = 0.04 unadjusted for ambulatory status and centre, p = 0.01 adjusted). There was suggestive evidence for treatment effects of D 9 -THC on some aspects of disability. There were no major safety concerns. Overall, ...
6
The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
... implicates cannabinoids as powerful regulators of cell growth and dif- ...of cannabinoids, research from the past two decades has demonstrated their promising potential as antitumor agents in a wide variety ...
18
Clinical Presentation of Intoxication Due to Synthetic Cannabinoids
... as drugs of abuse was bolstered by a 2008 re- port by the German media that this product could produce a marijuana- like high, but could not be detected on routine drug ...synthetic cannabinoids are ...
6